Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 11 kDa, reducing conditons. MW (theoretical): 7.8 kDa. The Recombinant Canine CCL4/MIP-1 beta Protein from R&D Systems is derived from E. coli. The Recombinant Canine CCL4/MIP-1 beta Protein has been validated for the following applications: Bioactivity.
Size
25 ug
Concentration
n/a
Applications
Bioactivity
Other Names
ACT2, ACT-2, AT744.1, C-C motif chemokine 4, chemokine (C-C motif) ligand 4, Exodus-3, G-26, G-26 T-lymphocyte-secreted protein, HC21, LAG1, LAG-1, Lymphocyte activation gene 1 protein, Macrophage inflammatory protein 1-beta, MIP1 beta, MIP-1 beta, MIP1B, MIP1B1, MIP-1-beta, MIP-1-beta(1-69), PAT 744, Protein H400, SCYA2, SCYA4, secreted protein G-26, SIS-gamma, small inducible cytokine A4 (homologous to mouse Mip-1b), Small-inducible cytokine A4, T-cell activation protein 2